Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream
Clinical trial NCT05220293 · TERMINATED
Trial details
- NCT number
- NCT05220293
- Sponsor
- Oticara Australia PTY LTD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2023-12-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.